Morgan Stanley analyst Erik Woodring maintains Dell Technologies (NYSE:DELL) with a Equal-Weight and lowers the price target from $56 to $54.
Ladenburg Thalmann Downgrades NextCure to Neutral
Ladenburg Thalmann analyst Aydin Huseynov downgrades NextCure (NASDAQ:NXTC) from Buy to Neutral.